| Evaluation of the cytotoxicity of β-cyclodextrin derivatives: Evidence for the role of cholesterol extraction T Kiss, F Fenyvesi, I Bácskay, J Váradi, E Fenyvesi, R Iványi, L Szente, ... European journal of pharmaceutical sciences 40 (4), 376-380, 2010 | 238 | 2010 |
| Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer Z Ujhelyi, F Fenyvesi, J Váradi, P Fehér, T Kiss, S Veszelka, M Deli, ... European Journal of Pharmaceutical Sciences 47 (3), 564-573, 2012 | 193 | 2012 |
| Cyclodextrins in drug delivery systems and their effects on biological barriers Á Haimhoffer, Á Rusznyák, K Réti-Nagy, G Vasvári, J Váradi, ... Scientia Pharmaceutica 87 (4), 33, 2019 | 162 | 2019 |
| “Back to the future”: a new look at hydroxypropyl beta-cyclodextrins M Malanga, J Szemán, É Fenyvesi, I Puskás, K Csabai, G Gyémánt, ... Journal of pharmaceutical sciences 105 (9), 2921-2931, 2016 | 131 | 2016 |
| Cyclodextrins, blood–brain barrier, and treatment of neurological diseases M Vecsernyés, F Fenyvesi, I Bácskay, MA Deli, L Szente, É Fenyvesi Archives of medical research 45 (8), 711-729, 2014 | 115 | 2014 |
| Raft and cytoskeleton associations of an ABC transporter: P‐glycoprotein Z Bacso, H Nagy, K Goda, L Bene, F Fenyvesi, J Matkó, G Szabó Cytometry Part A: The Journal of the International Society for Analytical …, 2004 | 101 | 2004 |
| P-glycoprotein inhibition by membrane cholesterol modulation F Fenyvesi, E Fenyvesi, L Szente, K Goda, Z Bacsó, I Bácskay, J Váradi, ... European journal of pharmaceutical sciences 34 (4-5), 236-242, 2008 | 93 | 2008 |
| Fluorescently labeled methyl-beta-cyclodextrin enters intestinal epithelial Caco-2 cells by fluid-phase endocytosis F Fenyvesi, K Réti-Nagy, Z Bacsó, Z Gutay-Tóth, M Malanga, É Fenyvesi, ... PloS one 9 (1), e84856, 2014 | 89 | 2014 |
| Evaluation of the cytotoxicity of α-cyclodextrin derivatives on the caco-2 cell line and human erythrocytes E Róka, Z Ujhelyi, M Deli, A Bocsik, É Fenyvesi, L Szente, F Fenyvesi, ... Molecules 20 (11), 20269-20285, 2015 | 80 | 2015 |
| Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody K Goda, F Fenyvesi, Z Bacso, H Nagy, T Marian, A Megyeri, Z Krasznai, ... Journal of Pharmacology and Experimental Therapeutics 320 (1), 81-88, 2007 | 73 | 2007 |
| Physico-chemical characterization of self-emulsifying drug delivery systems Z Ujhelyi, M Vecsernyés, P Fehér, D Kósa, P Arany, D Nemes, D Sinka, ... Drug Discovery Today: Technologies 27, 81-86, 2018 | 62 | 2018 |
| Endocytosis of fluorescent cyclodextrins by intestinal Caco-2 cells and its role in paclitaxel drug delivery K Réti-Nagy, M Malanga, É Fenyvesi, L Szente, G Vámosi, J Váradi, ... International journal of pharmaceutics 496 (2), 509-517, 2015 | 60 | 2015 |
| Role of cytotoxicity experiments in pharmaceutical development I Bácskay, D Nemes, F Fenyvesi, J Váradi, G Vasvári, P Fehér, ... Cytotoxicity 8, 131-46, 2018 | 59 | 2018 |
| Antioxidant and hepatoprotective activity of milk thistle (Silybum marianum L. Gaertn.) seed oil A Hermenean, M Stan, A Ardelean, L Pilat, CV Mihali, C Popescu, L Nagy, ... Open life sciences 10 (1), 2015 | 55 | 2015 |
| Efficacy of Pre- and Post-Treatment by Topical Formulations Containing Dissolved and Suspended Silybum marianum against UVB-Induced Oxidative Stress in … P Fehér, Z Ujhelyi, J Váradi, F Fenyvesi, E Róka, B Juhász, B Varga, ... Molecules 21 (10), 1269, 2016 | 54 | 2016 |
| Cyclodextrin complexation improves the solubility and Caco-2 permeability of chrysin F Fenyvesi, TLP Nguyen, Á Haimhoffer, Á Rusznyák, G Vasvári, I Bácskay, ... Materials 13 (16), 3618, 2020 | 50 | 2020 |
| Matrix systems for oral drug delivery: Formulations and drug release G Vasvári, J Kalmár, P Veres, M Vecsernyés, I Bácskay, P Fehér, Z Ujhelyi, ... Drug Discovery Today: Technologies 27, 71-80, 2018 | 45 | 2018 |
| Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies H Nagy, K Goda, F Fenyvesi, Z Bacsó, M Szilasi, J Kappelmayer, ... Biochemical and biophysical research communications 315 (4), 942-949, 2004 | 45 | 2004 |
| The enhanced inhibitory effect of different antitumor agents in self-microemulsifying drug delivery systems on human cervical cancer HeLa cells Z Ujhelyi, A Kalantari, M Vecsernyés, E Róka, F Fenyvesi, R Póka, ... Molecules 20 (7), 13226-13239, 2015 | 43 | 2015 |
| Reduced miR-26b expression in megakaryocytes and platelets contributes to elevated level of platelet activation status in sepsis B Szilágyi, Z Fejes, S Póliska, M Pócsi, Z Czimmerer, A Patsalos, ... International Journal of Molecular Sciences 21 (3), 866, 2020 | 42 | 2020 |
